Physician profile
Bennett Vitug
NPI 1154987139
$465.95
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $129 · 2021: $181 · 2022: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.74 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $86.46 | 2021-2022 | |
| Pfizer INC. | $33.76 | 2021-2022 | |
| Abbvie INC. | $29.77 | 2020-2021 | |
| Becton, Dickinson and Company | $27.17 | 2020 | |
| Amgen INC. | $23.54 | 2020 | |
| Lucid Diagnostics INC. | $22.25 | 2022 | |
| Amarin Pharma, INC. | $19.68 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.62 | 2020 | |
| Ibsa Pharma INC. | $17.46 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.46 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.74 | 2022 | |
| Radius Health, INC. | $11.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Vitug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.